GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Aoxing Pharmaceutical Company AOXG · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Aoxing Pharmaceutical Company

Its shares trade under the ticker AOXG. It has been listed since 28 May 2002. In the fiscal year to 30 June 2026, it reported revenue of $33,471 and a net loss of $23,378.

Aoxing Pharmaceutical Co., Inc. engages in the research, development, manufacture, and distribution of a variety of narcotics and pain management products. The company is headquartered in Foster City, California. The company went IPO on 2002-05-28. The firm holds approximately 140 drug production certificates covering narcotic pain-management, prescription medicines, over-the-counter (OTC) and active pharmaceutical ingredient (API) products. Its products include prescription drugs, such as Tilidine hydrochloride, Zhongtong'an and Humifuse Euphorbia Herb Tablet, and OTC drugs, such as Shanmei Capsule, Shaoshang Tincture, Yiqi Qiangshen Granule, Xiaopiling Granule, Xiongjushangqing Tablet, Juyuansuanbijia Oral Solutions, Longdanxiegan Tablet, Fenka Tablet, Shujinhuoxue Tablet, Fuketiaojing Tablet, Qingnao Jiangya Tablet, Yuanhu Pain Management Tablet, Bushenqiangshen Tablet, Baiziyangxin Pill, Qingguo Pill, Liuweidihuang Pill, Zhibaidihuang Pill, Xiaoyao Pill and Tianwangbuxin Pill.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Pharmaceuticals
Listed since
28 May 2002
Employees
339

Leadership

Pay as last reported

  • Mr. Zhenjiang YueChairman of the Board, Chief Executive Officer, since 2008$155,316
  • Mr. Guoan ZhangChief Financial Officer
  • Ms. Guirong ZhouPresident - Research and Development
  • Mr. Jun MinDirector
  • Ms. Yang LiIndependent Director
  • Dr. Guozhu XuIndependent Director
  • Mr. Yuelin ZhangIndependent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Aoxing Pharmaceutical Company Inc possesses several strengths that contribute to its success in the pharmaceutical industry. These include:

Weaknesses

  • Despite its strengths, Aoxing Pharmaceutical Company Inc faces certain weaknesses that may hinder its growth and competitive advantage. These include:

Opportunities

  • Aoxing Pharmaceutical Company Inc has several opportunities that it can leverage to further expand its market presence and profitability. These opportunities include:

Threats

  • Aoxing Pharmaceutical Company Inc also faces certain threats that could negatively impact its business. These threats include:

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.